D&A
ResMed D&A increased by 18.2% to $58.98M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 35.0%, from $43.68M to $58.98M. Over 4 years (FY 2021 to FY 2025), D&A shows an upward trend with a 6.1% CAGR.
Analysis
How to read this metric
Higher levels indicate significant capital investment in infrastructure or acquisitions, while lower levels may suggest aging assets or limited capital expenditure.
Detailed definition
This represents the non-cash expense allocated to the cost of tangible and intangible assets over their useful lives. Be...
Peer comparison
High in capital-intensive industries like manufacturing and healthcare devices; lower in service-based sectors.
depreciation_and_amortization_cfHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.72M | $39.10M | $40.79M | $42.31M | $37.41M | $36.27M | $37.77M | $44.36M | $46.76M | $44.93M | $44.78M | $43.47M | $43.68M | $44.73M | $46.44M | $43.68M | $63.63M | $47.70M | $49.89M | $58.98M |
| QoQ Change | — | +6.5% | +4.3% | +3.7% | -11.6% | -3.0% | +4.1% | +17.4% | +5.4% | -3.9% | -0.3% | -2.9% | +0.5% | +2.4% | +3.8% | -6.0% | +45.7% | -25.0% | +4.6% | +18.2% |
| YoY Change | — | — | — | — | +1.9% | -7.2% | -7.4% | +4.8% | +25.0% | +23.9% | +18.6% | -2.0% | -6.6% | -0.5% | +3.7% | +0.5% | +45.7% | +6.6% | +7.4% | +35.0% |
Business Segments — Total Sleep and Respiratory Care
| Segment | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 |
|---|---|---|---|---|---|---|---|---|
| Sleep and Respiratory Care | $19.77M | $18.53M | $21.20M | $23.04M | $20.52M | $21.96M | $21.83M | $21.76M |
| Total | $36.27M | $37.77M | $44.36M | $46.76M | $44.93M | $44.78M | $43.47M | $43.68M |
Software as a Service is derived from annual filings.
Sleep and Respiratory Care, Software as a Service, Total Sleep and Respiratory Care were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Business Segments — Sleep And Breathing Health
| Segment | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|
| Sleep And Breathing Health | $23.02M | $25.25M | $22.82M | $39.46M | $25.03M | $27.31M | $36.86M |
| Residential Care Software | $2.37M | $2.24M | $2.25M | $2.61M | $2.62M | $2.73M | $2.75M |
| Total | $44.73M | $46.44M | $43.68M | $63.63M | $47.70M | $49.89M | $58.98M |
D&A at Other Companies
Frequently Asked Questions
- What is ResMed's d&a?
- ResMed (RMD) reported d&a of $58.98M in Q1 2026.
- How has ResMed's d&a changed year-over-year?
- ResMed's d&a increased by 35.0% year-over-year, from $43.68M to $58.98M.
- What is the long-term trend for ResMed's d&a?
- Over 4 years (2021 to 2025), ResMed's d&a has grown at a 6.1% compound annual growth rate (CAGR), from $156.76M to $198.47M.
- What does d&a mean?
- The non-cash accounting expense for the wear and tear or expiration of assets.